Episode 12 - August 12th 2020

Brett J. Greene- Founder of http://adeliatx.com/ (Adelia Therapeutics)

Presented by https://www.paulaustin.co/ (Paul Austin) of https://thethirdwave.co/ (The Third Wave)

Adelia Therapeutics

Brett has been an advocate for psychedelic research and education for over 20 years. He is the Research Administrator for the Center for Drug Discovery at Northeastern University, a position he has held for more than 10 years. He has co-managed over $80m in grant funding to support cannabinoid and serotonin research. He co-founded Psymposia in 2014, a prominent media and events company globally recognized for its social, political, and scientific coverage of the psychedelic movement, as well as having held numerous conferences and events around the globe.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 11 - July 22nd 2020

Ian McDonald - Founder of https://brightmindsbio.com/ (Bright Minds Biosciences)

Presented by Paul Austin of The Third Wave

Bright Minds Biosciences

Bright Minds is a biotechnology company with veteran drug hunters creating the next generation of psychedelics to treat mental health disorders. Ian is the Founder at Bright Minds Biosciences and is responsible for developing the overall strategic vision as well as adroitly assembling the intellectual and capital resources to bring scientific innovations to market.

Prior to Bright Minds, he served on the management team at Avnel Gold – a TSX-listed gold mining, exploration, and development company with operations in Southwestern Mali in West Africa. In that capacity, McDonald developed and implemented the corporate strategy as it relates to MandA and capital markets resulting in a $160 million sale to Endeavor Mining within one year.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 10 - July 15th 2020

Natasha de Jong - Co-Founder and CEO at https://earthresonance.bio/ (Earth Resonance)

Presented by https://www.paulaustin.co/ (Paul Austin) of https://thethirdwave.co/ (The Third Wave)

Earth Resonance

Natasha de Jong is the co-founder and CEO of Earth Resonance. With Earth Resonance, we are the no1. microdosing company for personal, spiritual and therapeutical transformation.

Earth Resonance believes in medicine from the Earth, not from a lab. That is why we take an integrated approach. With our protocols, therapists and healing fungi, we raise your frequency naturally and offer life changing tools which supports this transformational process.

Earth Resonance is located in the Netherlands and work together with industry leaders with more than 20 years of experience in the field of cultivating fresh psychedelic sclerotia. The company is proud to share with you their journey, testimonials of transformation and are looking forward to speak to you about the revolution of consciousness with psychedelics, botanicals and healing frequencies.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 9 - July 8th 2020

Ronan Levy - Executive Chairman at https://www.fieldtriphealth.com/ (Field Trip Health)

Presented by Alana Armstrong of https://alanaldous.com/ (Alan Aldous)

Field Trip Health

Co-founder of Field Trip Psychedelics, a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and a director for Trait Biosciences Inc.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 8 - July 1st 2020

David Wood - Partner at https://www.blg.com/ (Borden Ladner Gervais LLP)

Presented by Alana Armstrong of https://alanaldous.com/ (Alan Aldous)

Borden Ladner Gervais LLP

Borden Ladner Gervais LLP (BLG) delivers comprehensive legal solutions and client services for domestic and international clients — across more practice areas and industry sectors — than any other Canadian firm. BLG is the largest full-service law firm in Canada with over 700 lawyers, intellectual property agents and other professionals serving businesses and institutions across all legal needs.

David holds a PhD in biochemistry and his formal graduate-level education in structural biochemistry, organic chemistry, physical chemistry, plant biochemistry, and natural products chemistry provides a strong technical background for advising clients in the Canadian cannabis industry in relation to both intellectual property and regulatory law.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 7 - June 24th 2020

Timothy Ko - CEO of https://entheonbiomedical.com/ (Entheon Biomedical)

Presented by https://www.paulaustin.co/ (Paul Austin) of https://thethirdwave.co/ (The Third Wave )

Entheon Biomedical

Entheon Biomedical is a biotechnology company committed to the development of safe and effective psychedelic medicines in order to provide patients with access to evidence-based treatments for addiction disorders.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 6 - June 17th 2020

Danny Motyka - CEO of https://www.psygen.ca/ (Psygen)

Presented by https://thethirdwave.co/ (Paul Austin) of https://thethirdwave.co/ (Third Wave)

Psygen

Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications. Danny Motyka has long been a proponent of psychedelic medicine. Personal experience with psilocybin and LSD helped him understand and manage major depression, and ultimately inspired him to dedicate his attention to psychedelic medicinal chemistry. After graduating from the University of Victoria with an honours degree in chemistry, he began his rise through management at Aurora Cannabis. His career with Aurora included multiple years as General Manager of a cannabis cultivation and processing facility, providing foundational experience with the intricacies of good manufacturing practices, and a strong knowledge of the Controlled Drugs and Substances Act and the associated regulations.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 5 - June 10th 2020

James Lanthier - CEO at https://www.mindsetpharma.com/ (Mindset Pharma)

Presented by https://thethirdwave.co/ (Paul Austin)

Mindset Pharma

Mindset is a psychedelic-based biopharmaceutical company that is focused on creating and developing a proprietary library of novel and patentable psychedelic therapeutics for the treatment of neurological and psychiatric disorders. James Lanthier is a seasoned technology executive with strong expertise in business building and corporate finance. Most recently, Mr. Lanthier co-founded Future Fertility, the leading developer of Artificial Intelligence applications for human infertility. Previously, was a founder and COO of Mood Media Corporation, which he grew along with the founding team to be the world's largest in-store media provider, serving over 300,000 retail and hospitality locations around the globe.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 4 - June 3rd 2020

Judy Blumstock - CEO at Diamond Therapeutics

Presented by https://alanaldous.com/ (Alana Armstrong)

DIAMOND THERAPEUTICS

Diamond Therapeutics is developing FDA-approved, psilocybin-based therapeutics that deliver patient benefits without undesired perceptual side effects.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Episode 3 - May 27th 2020

Susan Chapelle - Co-CEO at HAVN Life

Presented by https://alanaldous.com/ (Alana Armstrong)

HAVN LIFE

HAVN is creating standardized formulas using psychoactive compounds for scientific research and natural health care products for human performance.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.